Vincenzo Giallombardo

Dr. Vincenzo Giallombardo

ASP Palermo, Palermo, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MDMariano Catello Di Donna
Mariano Catello Di Donna
GCGIUSEPPE CUCINELLA
GIUSEPPE CUCINELLA
GZGiulia Zaccaria
Giulia Zaccaria
GRGiuseppe Lo Re
Giuseppe Lo Re
ACAgata Crapanzano
Agata Crapanzano
VCVito Chiantera
Vito Chiantera
Objective: To identify the best method among the radiologic, laparoscopic and laparotomic scoring assessment to predict the outcomes of cytoreductive surgery in patients with advanced ovarian cancer (AOC). Methods: Patients with AOC who underwent pre-operative computed tomography (CT) scan, laparoscopic evaluation, and cytoreductive surgery between August 2016 and February 2021 were retrospectively reviewed. Predictive Index (PI) score and Peritoneal Cancer Index (PCI) scores were used to estimate the tumor load and predict the residual disease in the primary debulking surgery (PDS) and interval debulking surgery (IDS) after neoadjuvant chemotherapy (NACT) groups. Concordance percentages were calculated between the two scores. Results: Among 100 eligible patients, 69 underwent PDS, and 31 underwent NACT and IDS. Complete cytoreduction was achieved in 72.5% of patients in the PDS group and 77.4% in the IDS. In patients undergoing PDS, the laparoscopic PI and the laparotomic PCI had the best accuracies for complete cytoreduction (R0) [area under the curve (AUC) = 0.78 and AUC = 0.83, respectively]. In the IDS group, the laparotomic PI (AUC = 0.75) and the laparoscopic PCI (AUC= 0.87) were associated with the best accuracy in R0 prediction. Furthermore, radiological assessment, through PI and PCI, was associated with the worst accuracy in either PDS or IDS group (PI in PDS: AUC = 0.64; PCI in PDS: AUC = 0.64; PI in IDS: AUC = 0.46; PCI in IDS: AUC = 0.47). Conclusion: The laparoscopic score assessment had high accuracy for optimal cytoreduction in AOC patients undergoing PDS or IDS. Integrating diagnostic laparoscopy in the decision-making algorithm to accurately triage AOC patients to different treatment strategies seems necessary.

Verified
Journal Article
Open access
PDF file
MDMariano Catello Di Donna
Mariano Catello Di Donna
VGVincenzo Giallombardo
Vincenzo Giallombardo
GBGiuseppina Lo Balbo
Giuseppina Lo Balbo
GCGIUSEPPE CUCINELLA
GIUSEPPE CUCINELLA
GSGiulio Sozzi
Giulio Sozzi
VCVito Chiantera
Vito Chiantera
Aortic lymph node metastases are a relative common finding in locally advanced cervical cancer. Minimally invasive surgery is the preferred approach to perform para-aortic lymph nodal staging to reduce complications, hospital stay, and the time to primary treatment. This meta-analysis (CRD42022335095) aimed to compare the surgical outcomes of the two most advanced approaches for the aortic staging procedure: conventional laparoscopy (CL) versus robotic-assisted laparoscopy (RAL). The meta-analysis was conducted according to the PRISMA guideline. The search string included the following keywords: “Laparoscopy” (MeSH Unique ID: D010535), “Robotic Surgical Procedures” (MeSH Unique ID: D065287), “Lymph Node Excision” (MeSH Unique ID: D008197) and “Aorta” (MeSH Unique ID: D001011), and “Uterine Cervical Neoplasms” (MeSH Unique ID: D002583). A total of 1324 patients were included in the analysis. Overall, 1200 patients were included in the CL group and 124 patients in the RAL group. Estimated blood loss was significantly higher in CL compared with RAL (p = 0.02), whereas hospital stay was longer in RAL compared with CL (p = 0.02). We did not find significant difference for all the other parameters, including operative time, intra- and postoperative complication rate, and number of lymph nodes excised. Based on our data analysis, both CL and RAL are valid options for para-aortic staging lymphadenectomy in locally advanced cervical cancer.

4 October 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MDMariano Catello Di Donna
Mariano Catello Di Donna
GCGIUSEPPE CUCINELLA
GIUSEPPE CUCINELLA
VGVincenzo Giallombardo
Vincenzo Giallombardo
GBGiuseppina Lo Balbo
Giuseppina Lo Balbo
Vito Andrea CapozziVito Andrea Capozzi
Vito Andrea Capozzi
VCVito Chiantera
Vito Chiantera

28 September 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
GSGiulio Sozzi
Giulio Sozzi
SLSonia Lauricella
Sonia Lauricella
GCGIUSEPPE CUCINELLA
GIUSEPPE CUCINELLA
Vito Andrea CapozziVito Andrea Capozzi
Vito Andrea Capozzi
Roberto BerrettaRoberto Berretta
Roberto Berretta
VCVito Chiantera
Vito Chiantera